Serious adverse events · Patients with presumed drug‐sensitive TB
Fluoroquinolone substitution for isoniazid in a standard six month… showed no clear difference in serious adverse events compared with standard regimen (low certainty).
1 finding from 1 review
Serious adverse events · Patients with presumed drug‐sensitive TB
It is very uncertain whether fluoroquinolone plus standard regimen changes serious adverse events compared with standard regimen alone (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults with trichotillomania
1 finding from 1 review
Dropouts due to adverse events · adults with trichotillomania
It is very uncertain whether TCAs with predominantly SRI actions changes tolerability of treatment ‐ dropouts due to adverse eventsdDropout… compared with placebo (very low certainty).
1 finding from 1 review
adverse events(6 weeks) · depression in adults
1 finding from 1 review
Maternal adverse events · pregnant women and their infants..
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Severe adverse events11 · Pregnant women (parity 2+)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Maternal adverse events · pregnant women at term.
1 finding from 1 review
Serious adverse events ( · preventing the progression of CKD
Metformin showed no clear difference in serious adverse events ( compared with active control (moderate certainty).
1 finding from 1 review
Serious adverse events ( · preventing the progression of CKD
Metformin showed no clear difference in serious adverse events ( compared with placebo (moderate certainty).
1 finding from 1 review
adverse events(12 weeks) · depression in adults
1 finding from 1 review
adverse events(16 weeks) · depression in adults
1 finding from 1 review
adverse events(16 weeks) · depression in adults
1 finding from 1 review
Treatment‐related adverse events Depression · adults (aged 16 years and over) with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
adverse events (16 weeks) · depression in adults
1 finding from 1 review
Adverse events: ED visits · people with pressure ulcers residing in long‐term‐care facilities
1 finding from 1 review
Maternal adverse events · pregnant women undergoing caesarean section
1 finding from 1 review
adverse events(8‐10 weeks) · depression in adults
1 finding from 1 review
Adverse events, short‐term · people of any age with an existing pressure ulcer of Category/Stage II or above
It is very uncertain whether foam dressing changes adverse events, short‐term compared with hydrogel dressing (very low certainty).
1 finding from 1 review
Adverse events, short‐term · people of any age with an existing pressure ulcer of Category/Stage II or above
It is very uncertain whether hydropolymer foam dressing changes adverse events, short‐term compared with silicone foam dressing (very low certainty).
1 finding from 1 review